TrialJournal of gastroenterology2019

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.

Mitsutaka Osawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.